Publication Date:
1982-07-16
Description:
The ability of antiserum against murine L1210 leukemia to remove residual leukemia cells from murine bone marrow was investigated. Leukemic marrow was treated in vitro with antiserum and complement and used to hematologically reconstitute mice that had been irradiated with doses lethal to bone marrow. Following infusion of treated leukemic marrow, normal marrow returned without evidence of leukemia. More than 90 percent of the animals have survived for 11 months without untoward effects, suggesting that the technique may be of use in the treatment of acute leukemia in humans.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Trigg, M E -- Poplack, D G -- New York, N.Y. -- Science. 1982 Jul 16;217(4556):259-61.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/7046048" target="_blank"〉PubMed〈/a〉
Keywords:
Animals
;
*Antibodies
;
*Bone Marrow Transplantation
;
Cell Survival
;
*Complement System Proteins
;
Cytotoxicity, Immunologic
;
Female
;
Leukemia L1210/*immunology/therapy
;
Male
;
Mice
;
Mice, Inbred DBA
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink
